CoChat

Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer’s disease

Open access
Tseng, Hui-Ju, Lin, Mei-Hsiang, Shiao, Young-Ji, Yang, Ying-Chen, Chu, Jung-Chun, Chen, Chun-Yung, Chen, Yi-Ying, Lin, Tony Eight, Su, Chih-Jou, Pan, Shiow-Lin, Chen, Liang-Chieh, Wang, Chen-Yu, Hsu, Kai-Cheng, Huang, Wei-Jan · 2020 · European Journal of Medicinal Chemistry
Cited by 53

The DOI matches its Crossref record; 12 of the 12 references it cites were found in a registry or an index.

Abstract

Multitarget agents simultaneously trigger molecules in functionally complementary pathways, and are therefore considered to have potential in effectively treating Alzheimer's disease (AD), which has a complex pathogenetic mechanism. In this study, the HDAC inhibitor core is incorporated into the acetylcholine esterase (ACE) inhibitor acridine-derived moiety and resulted in compounds that exhibited higher class IIa HDAC (4, 5, 7, and 9)- and class IIb HDAC6-inhibiting activity when compared to the pan-HDAC inhibitor SAHA in clinical practice. One of these compounds, 11b, displayed greater selectivity toward HDAC6 than other isoform enzymes. In contrast, the activity of compound 6a was selective toward class IIa HDAC and HDAC6. These two compounds exhibited strong activity against Aβ-aggregation as well as significantly disrupted Aβ-oligomer. Additionally, 11b and 6a strongly inhibited AChE. These experimental findings demonstrate that compounds 11b and 6a are HDAC-Aβ-aggregation-AChE inhibitors. Notably, they can enhance neurite outgrowth, but with no significant neurotoxicity. Further biological evaluation revealed the various cellular effects of multitarget compounds 11b and 6a, which have the potential to treat AD.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.ejmech.2020.112193

Cites

12 of 12 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 12 references

Cited by

See all 53

Metadata

Authors
Tseng, H.-J., Lin, M.-H., Shiao, Y.-J., Yang, Y.-C., Chu, J.-C., Chen, C.-Y., Chen, Y.-Y., Lin, T. E., Su, C.-J., Pan, S.-L., Chen, L.-C., Wang, C.-Y., Hsu, K.-C., & Huang, W.-J.
Venue
European Journal of Medicinal Chemistry
Publisher
Elsevier BV
Published
2020-04
Volume
192
Pages
112193
ISSN
0223-5234 (ISSN-L)
OpenAlex
W3008086680
Cited by
53
References
12
FWCI
3.41
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer’s disease. https://app.cochat.ai/papers/10.1016/j.ejmech.2020.112193
The paper
Tseng, H.-J., Lin, M.-H., Shiao, Y.-J., Yang, Y.-C., Chu, J.-C., Chen, C.-Y., Chen, Y.-Y., Lin, T. E., Su, C.-J., Pan, S.-L., Chen, L.-C., Wang, C.-Y., Hsu, K.-C., & Huang, W.-J. (2020). Synthesis and biological evaluation of acridine-based histone deacetylase inhibitors as multitarget agents against Alzheimer’s disease. European Journal of Medicinal Chemistry. https://doi.org/10.1016/j.ejmech.2020.112193

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.